Back
Recursion Pharmaceuticals Stock Price Chart
Unlock the Secret to Earning Monthly Income!
Limited spots act swiftly
Buy
62
RXRX
Recursion Pharmaceuticals
Last Price:
8.85
Seasonality Move:
67.46%
7 Day Trial
ALL ACCESS PASS
$
7
$50 trade to make today with huge potential!
Click here to access my #1 options strategy for overnight wins starting with $50!- The current trend is relatively stagnant and RXRX is experiencing selling pressure, which indicates risk of future bearish movement.
Recursion Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.24 | Buy |
| 20-day SMA: | 8.14 | Buy |
| 50-day SMA: | 9.95 | Sell |
| 200-day SMA: | 9.22 | Sell |
| 8-day EMA: | 8.34 | Buy |
| 20-day EMA: | 8.43 | Buy |
| 50-day EMA: | 9.22 | Sell |
| 200-day EMA: | 9.26 | Sell |
Recursion Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.34 | Sell |
| Relative Strength Index (14 RSI): | 52.55 | Buy |
| Chaikin Money Flow: | -2357690 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.7 - 8.9) | Buy |
| Bollinger Bands (100): | (8.46 - 11.94) | Sell |
Recursion Pharmaceuticals Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Recursion Pharmaceuticals Stock
Is Recursion Pharmaceuticals Stock a Buy?
- Recursion Pharmaceuticals share price is 8.84 while RXRX 8-day simple moving average is 8.24, which is a Buy signal.
- The stock price of RXRX is 8.84 while Recursion Pharmaceuticals 20-day SMA is 8.14, which makes it a Buy.
- Recursion Pharmaceuticals 50-day simple moving average is 9.95 while RXRX share price is 8.84, making it a Sell technically.
- RXRX stock price is 8.84 and Recursion Pharmaceuticals 200-day simple moving average is 9.22, creating a Sell signal.
RXRX Technical Analysis vs Fundamental Analysis
Buy
62
Recursion Pharmaceuticals (RXRX)
is a Buy
Is Recursion Pharmaceuticals a Buy or a Sell?
-
Recursion Pharmaceuticals stock is rated a Buy
The current Recursion Pharmaceuticals [RXRX] share price is $8.84. The Score for RXRX is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
Recursion Pharmaceuticals Stock Info
Market Cap:
2.07B
Price in USD:
8.84
Share Volume:
3.93M
Recursion Pharmaceuticals 52-Week Range
52-Week High:
16.75
52-Week Low:
4.92
Buy
62
Recursion Pharmaceuticals (RXRX)
is a Buy
Recursion Pharmaceuticals Share Price Forecast
-
What is the Recursion Pharmaceuticals stock price today?
The Recursion Pharmaceuticals stock price is 8.84 USD today. -
Will RXRX stock go up or go down?
Recursion Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Recursion Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Recursion Pharmaceuticals is not overvalued.
Is Recursion Pharmaceuticals Stock a Buy?
- Recursion Pharmaceuticals share price is 8.84 while RXRX 8-day exponential moving average is 8.34, which is a Buy signal.
- The stock price of RXRX is 8.84 while Recursion Pharmaceuticals 20-day EMA is 8.43, which makes it a Buy.
- Recursion Pharmaceuticals 50-day exponential moving average is 9.22 while RXRX share price is 8.84, making it a Sell technically.
- RXRX stock price is 8.84 and Recursion Pharmaceuticals 200-day simple moving average is 9.26, creating a Sell signal.
Fundamental Analysis of Recursion Pharmaceuticals
Is Recursion Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.25 per share, a decrease this year of $0.08 per share, and a decrease next year of $0.13 per share.
Technical Analysis of Recursion Pharmaceuticals
Should I short Recursion Pharmaceuticals stock?
- RXRX Moving Average Covergence Divergence (MACD) indicator is -0.34, suggesting Recursion Pharmaceuticals is a Sell
- Recursion Pharmaceuticals Relative Strength Index (RSI) is 52.55, which suggest Recursion Pharmaceuticals is overbought
- The Bollinger Bands (25) for Recursion Pharmaceuticals is (7.7 - 8.9), which suggest Recursion Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Recursion Pharmaceuticals is (8.46 - 11.94), which suggest Recursion Pharmaceuticals is a Sell
* Recursion Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.